CosmaCMaiaCKhanN, et al.Leishmaniasis in humans and animals: a one health approach for surveillance, prevention and control in a changing world. Trop Med Infect Dis2024; 9: 258
2.
HajjaranHSaberiRBorjianAR, et al.The geographical distribution of human cutaneous and visceral Leishmania species identified by molecular methods in Iran: a systematic review with meta-analysis. Front Public Health2021; 9: 661674
3.
Zanjirani FarahaniLMohebaliMAkhoundiB, et al.Seroepidemiological study on visceral leishmaniasis in an endemic focus of central Iran during 2017. J Parasit Dis2019; 43: 22–27
4.
CostaCHNChangKPCostaDL, et al.From infection to death: an overview of the pathogenesis of visceral leishmaniasis. Pathogens2023; 12: 969
5.
LindosoJALMoreiraCHVCunhaMA, et al.Visceral leishmaniasis and HIV coinfection: current perspectives. HIV AIDS (Auckl)2018; 10: 193–201
6.
de LevalLESJ. Lymphoma classification. Cancer J2020; 26: 176–185
7.
PaquinAROyogoaEMcMurryHS, et al.The diagnosis and management of suspected lymphoma in general practice. Eur J Haematol2023; 110: 3–13
8.
KingRLGoodladJRCalaminiciM, et al.Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis. Virchow Arch2020; 476: 647–665
9.
NicolasGKouryEOsmanD, et al.Leishmania in a patient with small lymphocytic lymphoma/chronic lymphocytic leukemia. Am J Case Rep2018; 19: 512–516
10.
Torres-GuerreroEQuintanilla-CedilloMRRuiz-EsmenjaudJ, et al.Leishmaniasis: a review. F1000 Faculty Rev2017; 6: 750
11.
RahimSKarimMM. The elimination status of visceral leishmaniasis in Southeast Asia region. Acta Parasitol2024; 69: 1704–1716
12.
SarkariBNarakiTGhateeMA, et al.Visceral leishmaniasis in southwestern Iran: a retrospective clinico-hematological analysis of 380 consecutive hospitalized cases (1999–2014). PLoS One2016; 11: e0150406
13.
MohebaliMEdrissianGAkhoundiB, et al.Visceral leishmaniasis in Iran: an update on epidemiological features from 2013 to 2022. Iran J Parasitol2023; 18: 279–293
14.
KopteridesPMourtzoukouEGSkopelitisE, et al.Aspects of the association between leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg2007; 101: 1181–1189
15.
AfshoonMAbdolsalehiMAliniaG, et al. Disseminated leishmaniasis due to using immunosuppression drugs: a case report. Iran J Parasitol2020;15:278–281.
